Incyte Corp. sell Morgan Stanley
Start price
20.07.23
/
50%
€57.02
Target price
20.07.24
€66.25
Performance (%)
-14.40%
Price
30.04.24
€48.81
Summary
This prediction is currently active. The prediction for Incyte Corp. shows a convincing performance of -14.40%. This prediction currently runs until 20.07.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | 0.951% | 0.951% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Morgan_Stanley for this prediction
In the thread Incyte Corp. diskutieren
Incyte Co. (NASDAQ: INCY) had its "underweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $74.00 price target on the stock.
Ratings data for INCY provided by MarketBeat